| Year |
Citation |
Score |
| 2023 |
Apley KD, Griffith AS, Downes GM, Ross P, Farrell MP, Kendall P, Berkland CJ. CD22L Conjugation to Insulin Attenuates Insulin-Specific B Cell Activation. Bioconjugate Chemistry. PMID 37883211 DOI: 10.1021/acs.bioconjchem.3c00391 |
0.75 |
|
| 2023 |
Johnson SN, Brucks SD, Apley KD, Farrell MP, Berkland CJ. Multivalent Scaffolds to Promote B cell Tolerance. Molecular Pharmaceutics. PMID 37410969 DOI: 10.1021/acs.molpharmaceut.3c00039 |
0.772 |
|
| 2023 |
Chakravarti AR, Groer CE, Gong H, Yudistyra V, Forrest ML, Berkland CJ. Design of a Tumor Binding GMCSF as Intratumoral Immunotherapy of Solid Tumors. Molecular Pharmaceutics. PMID 36825806 DOI: 10.1021/acs.molpharmaceut.2c00897 |
0.532 |
|
| 2022 |
Huang A, Kurhade SE, Ross P, Apley KD, Griffin JD, Berkland CJ, Farrell MP. Disrupting N-Glycosylation Using Type I Mannosidase Inhibitors Alters B-Cell Receptor Signaling. Acs Pharmacology & Translational Science. 5: 1062-1069. PMID 36407961 DOI: 10.1021/acsptsci.2c00153 |
0.749 |
|
| 2020 |
Apley KD, Griffin JD, Johnson SN, Berkland CJ, DeKosky BJ. Tetrameric Fluorescent Antigen Arrays for Single-Step Identification of Antigen-Specific B Cells. Journal of Visualized Experiments : Jove. PMID 33165322 DOI: 10.3791/61827 |
0.756 |
|
| 2020 |
Groer C, Zhang T, Lu R, Cai S, Mull D, Huang A, Forrest M, Berkland CJ, Aires D, Forrest ML. Intratumoral cancer chemotherapy with a carrier-based immunogenic cell death eliciting platinum (IV) agent. Molecular Pharmaceutics. PMID 32975949 DOI: 10.1021/acs.molpharmaceut.0c00781 |
0.554 |
|
| 2019 |
Leon MA, Firdessa-Fite R, Ruffalo JK, Pickens CJ, Sestak JO, Creusot RJ, Berkland C. Soluble Antigen Arrays Displaying Mimotopes Direct the Response of Diabetogenic T Cells. Acs Chemical Biology. PMID 31260253 DOI: 10.1021/Acschembio.9B00090 |
0.318 |
|
| 2019 |
Lu R, Groer C, Kleindl PA, Moulder KR, Huang A, Hunt JR, Cai S, Aires DJ, Berkland C, Forrest L. Formulation and preclinical evaluation of a toll-like receptor 7/8 agonist as an anti-tumoral immunomodulator. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 31173789 DOI: 10.1016/J.Jconrel.2019.06.003 |
0.307 |
|
| 2019 |
Pickens CJ, Christopher MA, Leon MA, Pressnall MM, Johnson SN, Thati S, Sullivan BP, Berkland C. Antigen-Drug Conjugates as a Novel Therapeutic Class for the Treatment of Antigen-Specific Autoimmune Disorders. Molecular Pharmaceutics. PMID 31083955 DOI: 10.1021/Acs.Molpharmaceut.9B00063 |
0.341 |
|
| 2019 |
Leon MA, Wemlinger SM, Larson NR, Ruffalo JK, Middaugh CR, Cambier JC, Berkland C. Synthesis and Characterization of Multivalent Protein based Soluble Antigen Arrays for Juvenile Diabetes. Molecular Pharmaceutics. PMID 30681867 DOI: 10.1021/Acs.Molpharmaceut.8B01250 |
0.341 |
|
| 2018 |
Tima S, Okonogi S, Ampasavate C, Berkland C, Anuchapreeda S. FLT3-specific curcumin micelles enhance activity of curcumin on FLT3-ITD overexpressing MV4-11 leukemic cells. Drug Development and Industrial Pharmacy. 1-26. PMID 30572745 DOI: 10.1080/03639045.2018.1562462 |
0.36 |
|
| 2018 |
Hartwell BL, Pickens CJ, Leon M, Northrup L, Christopher MA, Griffin JD, Martinez-Becerra F, Berkland C. Soluble antigen arrays disarm antigen-specific B cells to promote lasting immune tolerance in experimental autoimmune encephalomyelitis. Journal of Autoimmunity. PMID 30007842 DOI: 10.1016/J.Jaut.2018.06.006 |
0.333 |
|
| 2018 |
Van Kampen E, Vandervelden C, Fakhari A, Qian J, Berkland C, Gehrke SH. Design of Hollow Hyaluronic Acid Cylinders for Sustained Intravitreal Protein Delivery. Journal of Pharmaceutical Sciences. PMID 29729900 DOI: 10.1016/J.Xphs.2018.04.024 |
0.332 |
|
| 2018 |
Ruiz SI, Bowen LE, Bailey MM, Berkland C. Pulmonary Delivery of Ceftazidime for the Treatment of Melioidosis in a Murine Model. Molecular Pharmaceutics. PMID 29363975 DOI: 10.1021/Acs.Molpharmaceut.7B00938 |
0.318 |
|
| 2017 |
Northrup L, Daniel Griffin J, Christopher MA, Antunez LR, Hartwell BL, Pickens CJ, Berkland C. Co-delivery of autoantigen and dexamethasone in incomplete Freund's adjuvant ameliorates experimental autoimmune encephalomyelitis. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 28963036 DOI: 10.1016/J.Jconrel.2017.09.034 |
0.32 |
|
| 2017 |
Kuehl C, Thati S, Sullivan B, Sestak J, Thompson M, Siahaan T, Berkland C. Pulmonary Administration of Soluble Antigen Arrays is Superior to Antigen in Treatment of Experimental Autoimmune Encephalomyelitis. Journal of Pharmaceutical Sciences. PMID 28625726 DOI: 10.1016/J.Xphs.2017.06.008 |
0.305 |
|
| 2017 |
Hartwell BL, Pickens CJ, Leon M, Berkland C. Multivalent antigen arrays exhibit high avidity binding and modulation of B cell receptor-mediated signaling to drive efficacy against experimental autoimmune encephalomyelitis. Biomacromolecules. PMID 28474886 DOI: 10.1021/Acs.Biomac.7B00335 |
0.352 |
|
| 2017 |
Mohammadi Z, Shangbin S, Berkland C, Liang Jt. Chelator-mimetic multi-functionalized hydrogel: Highly efficient and reusable sorbent for Cd, Pb, and As removal from waste water Chemical Engineering Journal. 307: 496-502. DOI: 10.1016/J.Cej.2016.08.121 |
0.31 |
|
| 2016 |
Tima S, Okonogi S, Ampasavate C, Pickens C, Berkland C, Anuchapreeda S. Development and Characterization of FLT3-specific Curcumin-loaded Polymeric Micelles as a Drug Delivery System for Treating FLT3-overexpressing Leukemic Cells. Journal of Pharmaceutical Sciences. PMID 27751588 DOI: 10.1016/J.Xphs.2016.09.010 |
0.389 |
|
| 2016 |
Ruiz SI, El-Gendy N, Bowen LE, Berkland C, Bailey MM. Formulation and Characterization of Nanocluster Ceftazidime for the Treatment of Acute Pulmonary Melioidosis. Journal of Pharmaceutical Sciences. PMID 27639659 DOI: 10.1016/J.Xphs.2016.07.029 |
0.317 |
|
| 2016 |
Kuehl C, Zhang T, Kaminskas LM, Porter CJ, Davies NM, Forrest ML, Berkland CJ. Hyaluronic Acid Molecular Weight Determines Lung Clearance and Biodistribution after Instillation. Molecular Pharmaceutics. PMID 27157508 DOI: 10.1021/Acs.Molpharmaceut.6B00069 |
0.613 |
|
| 2016 |
Hartwell BL, Martinez-Becerra F, Chen J, Shinogle HE, Sarnowski M, Moore DS, Berkland C. Antigen-Specific Binding of Multivalent Soluble Antigen Arrays Induces Receptor Clustering and Impedes B Cell Receptor Mediated Signaling. Biomacromolecules. PMID 26771518 DOI: 10.1021/Acs.Biomac.5B01097 |
0.327 |
|
| 2015 |
Hartwell BL, Smalter Hall A, Swafford D, Sullivan BP, Garza A, Sestak JO, Northrup L, Berkland C. Molecular Dynamics of Multivalent Soluble Antigen Arrays Support Two-Signal Codelivery Mechanism in Treatment of Experimental Autoimmune Encephalomyelitis. Molecular Pharmaceutics. PMID 26636828 DOI: 10.1021/Acs.Molpharmaceut.5B00825 |
0.329 |
|
| 2015 |
Pornputtapitak W, El-Gendy N, Berkland C. NanoCluster Itraconazole Formulations Provide a Potential Engineered Drug Particle Approach to Generate Effective Dry Powder Aerosols. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 28: 341-52. PMID 25679514 DOI: 10.1089/Jamp.2014.1155 |
0.777 |
|
| 2015 |
Thati S, Kuehl C, Hartwell B, Sestak J, Siahaan T, Forrest ML, Berkland C. Routes of administration and dose optimization of soluble antigen arrays in mice with experimental autoimmune encephalomyelitis. Journal of Pharmaceutical Sciences. 104: 714-21. PMID 25447242 DOI: 10.1002/Jps.24272 |
0.563 |
|
| 2015 |
Qian J, Berkland C. PH-sensitive triblock copolymers for efficient siRNA encapsulation and delivery Polymer Chemistry. 6: 3472-3479. DOI: 10.1039/C5Py00219B |
0.345 |
|
| 2014 |
Sestak JO, Sullivan BP, Thati S, Northrup L, Hartwell B, Antunez L, Forrest ML, Vines CM, Siahaan TJ, Berkland C. Codelivery of antigen and an immune cell adhesion inhibitor is necessary for efficacy of soluble antigen arrays in experimental autoimmune encephalomyelitis. Molecular Therapy. Methods & Clinical Development. 1: 14008. PMID 26015953 DOI: 10.1038/Mtm.2014.8 |
0.565 |
|
| 2014 |
Northrup L, Sestak JO, Sullivan BP, Thati S, Hartwell BL, Siahaan TJ, Vines CM, Berkland C. Co-delivery of autoantigen and b7 pathway modulators suppresses experimental autoimmune encephalomyelitis. The Aaps Journal. 16: 1204-13. PMID 25297853 DOI: 10.1208/S12248-014-9671-Y |
0.305 |
|
| 2014 |
Sestak JO, Fakhari A, Badawi AH, Siahaan TJ, Berkland C. Structure, size, and solubility of antigen arrays determines efficacy in experimental autoimmune encephalomyelitis. The Aaps Journal. 16: 1185-93. PMID 25193268 DOI: 10.1208/S12248-014-9654-Z |
0.328 |
|
| 2014 |
Kuehl C, El-Gendy N, Berkland C. NanoClusters surface area allows nanoparticle dissolution with microparticle properties. Journal of Pharmaceutical Sciences. 103: 1787-98. PMID 24788354 DOI: 10.1002/Jps.23980 |
0.385 |
|
| 2014 |
Pornputtapitak W, El-Gendy N, Mermis J, O'Brien-Ladner A, Berkland C. NanoCluster budesonide formulations enable efficient drug delivery driven by mechanical ventilation. International Journal of Pharmaceutics. 462: 19-28. PMID 24374223 DOI: 10.1016/J.Ijpharm.2013.12.030 |
0.786 |
|
| 2014 |
Fakhari A, Phan Q, Berkland C. Hyaluronic acid colloidal gels as self-assembling elastic biomaterials. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 102: 612-8. PMID 24124008 DOI: 10.1002/Jbm.B.33041 |
0.38 |
|
| 2014 |
Alhakamy NA, Kaviratna A, Berkland C, Dhar P. Membrane Insertion Potential of Synthetic Cell Penetrating Peptides Biophysical Journal. 106. DOI: 10.1016/J.Bpj.2013.11.607 |
0.311 |
|
| 2013 |
El-Gendy N, Kaviratna A, Berkland C, Dhar P. Delivery and performance of surfactant replacement therapies to treat pulmonary disorders. Therapeutic Delivery. 4: 951-80. PMID 23919474 DOI: 10.4155/Tde.13.72 |
0.304 |
|
| 2013 |
Wang Q, Gu Z, Jamal S, Detamore MS, Berkland C. Hybrid hydroxyapatite nanoparticle colloidal gels are injectable fillers for bone tissue engineering. Tissue Engineering. Part A. 19: 2586-93. PMID 23815275 DOI: 10.1089/Ten.Tea.2013.0075 |
0.322 |
|
| 2013 |
Alhakamy NA, Nigatu AS, Berkland CJ, Ramsey JD. Noncovalently associated cell-penetrating peptides for gene delivery applications. Therapeutic Delivery. 4: 741-57. PMID 23738670 DOI: 10.4155/tde.13.44 |
0.502 |
|
| 2013 |
Sestak J, Mullins M, Northrup L, Thati S, Forrest ML, Siahaan TJ, Berkland C. Single-step grafting of aminooxy-peptides to hyaluronan: a simple approach to multifunctional therapeutics for experimental autoimmune encephalomyelitis. Journal of Controlled Release : Official Journal of the Controlled Release Society. 168: 334-40. PMID 23541930 DOI: 10.1016/J.Jconrel.2013.03.015 |
0.606 |
|
| 2013 |
Fakhari A, Phan Q, Thakkar SV, Middaugh CR, Berkland C. Hyaluronic acid nanoparticles titrate the viscoelastic properties of viscosupplements. Langmuir : the Acs Journal of Surfaces and Colloids. 29: 5123-31. PMID 23514620 DOI: 10.1021/La304575X |
0.374 |
|
| 2013 |
Fang WB, Alhakamy N, Berkland C, Cheng N. Abstract A063: Targeting the CCL2 chemokine pathway in breast tumors through intratumoral delivery of calcium cross linked TAT peptide: siRNA complexes Molecular Cancer Research. 11. DOI: 10.1158/1557-3125.Advbc-A063 |
0.332 |
|
| 2013 |
Thaiboonrod S, Berkland C, Milani AH, Ulijn R, Saunders BR. Poly(vinylamine) microgels: PH-responsive particles with high primary amine contents Soft Matter. 9: 3920-3930. DOI: 10.1039/C3Sm27728C |
0.357 |
|
| 2012 |
El-Gendy N, Selvam P, Soni P, Berkland C. Development of budesonide nanocluster dry powder aerosols: preformulation. Journal of Pharmaceutical Sciences. 101: 3434-44. PMID 22623018 DOI: 10.1002/Jps.23197 |
0.344 |
|
| 2012 |
El-Gendy N, Huang S, Selvam P, Soni P, Berkland C. Development of budesonide nanocluster dry powder aerosols: formulation and stability. Journal of Pharmaceutical Sciences. 101: 3445-55. PMID 22619045 DOI: 10.1002/Jps.23176 |
0.365 |
|
| 2012 |
Bagby TR, Duan S, Cai S, Yang Q, Thati S, Berkland C, Aires DJ, Forrest ML. Lymphatic trafficking kinetics and near-infrared imaging using star polymer architectures with controlled anionic character. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 47: 287-94. PMID 22546180 DOI: 10.1016/J.Ejps.2012.04.016 |
0.644 |
|
| 2012 |
El-Gendy N, Selvam P, Soni P, Berkland C. Development of budesonide nanocluster dry powder aerosols: processing. Journal of Pharmaceutical Sciences. 101: 3425-33. PMID 22539360 DOI: 10.1002/Jps.23168 |
0.387 |
|
| 2012 |
Kawabata A, Baoum A, Ohta N, Jacquez S, Seo GM, Berkland C, Tamura M. Intratracheal administration of a nanoparticle-based therapy with the angiotensin II type 2 receptor gene attenuates lung cancer growth. Cancer Research. 72: 2057-67. PMID 22389453 DOI: 10.1158/0008-5472.Can-11-3634 |
0.329 |
|
| 2012 |
Pornputtapitak W, El-Gendy N, Berkland C. Nanocluster budesonide formulations enhance drug delivery through endotracheal tubes. Journal of Pharmaceutical Sciences. 101: 1063-72. PMID 22095757 DOI: 10.1002/Jps.22818 |
0.792 |
|
| 2012 |
Baoum A, Ovcharenko D, Berkland C. Calcium condensed cell penetrating peptide complexes offer highly efficient, low toxicity gene silencing. International Journal of Pharmaceutics. 427: 134-42. PMID 21856394 DOI: 10.1016/J.Ijpharm.2011.08.012 |
0.355 |
|
| 2012 |
Shang Q, Wang X, Apley M, Kukanich SB, Berkland C. PPF microsphere depot sustains NSAID blood levels with infusion-like kinetics without 'burst' Journal of Veterinary Pharmacology and Therapeutics. 35: 231-238. PMID 21696401 DOI: 10.1111/J.1365-2885.2011.01317.X |
0.325 |
|
| 2012 |
Kawabata A, Baoum A, Ohta N, Jacquez S, Berkland C, Tamura M. Abstract 5653: A novel cationic peptide nanoparticle-based gene therapy with angiotensin II type 2 receptor gene significantly attenuates growth of lung adenocarcinoma xenografts in mouse model Cancer Research. 72: 5653-5653. DOI: 10.1158/1538-7445.Am2012-5653 |
0.311 |
|
| 2012 |
Bailey MM, Kline SR, Anderson MD, Staymates JL, Berkland C. Chemically modifiable fluorinated copolymer nanoparticles for 19F-MRI contrast enhancement Journal of Applied Polymer Science. 126: 1218-1227. DOI: 10.1002/App.36889 |
0.326 |
|
| 2011 |
El-Gendy N, Pornputtapitak W, Berkland C. Nanoparticle agglomerates of fluticasone propionate in combination with albuterol sulfate as dry powder aerosols. European Journal of Pharmaceutical Sciences : Official Journal of the European Federation For Pharmaceutical Sciences. 44: 522-33. PMID 21964203 DOI: 10.1016/J.Ejps.2011.09.014 |
0.798 |
|
| 2011 |
Khondee S, Olsen CM, Zeng Y, Middaugh CR, Berkland C. Noncovalent PEGylation by polyanion complexation as a means to stabilize keratinocyte growth factor-2 (KGF-2). Biomacromolecules. 12: 3880-94. PMID 21954860 DOI: 10.1021/Bm2007967 |
0.769 |
|
| 2011 |
Khondee S, Baoum A, Siahaan TJ, Berkland C. Calcium condensed LABL-TAT complexes effectively target gene delivery to ICAM-1 expressing cells. Molecular Pharmaceutics. 8: 788-98. PMID 21473630 DOI: 10.1021/Mp100393J |
0.774 |
|
| 2011 |
Fakhari A, Baoum A, Siahaan TJ, Le KB, Berkland C. Controlling ligand surface density optimizes nanoparticle binding to ICAM-1. Journal of Pharmaceutical Sciences. 100: 1045-56. PMID 20922813 DOI: 10.1002/Jps.22342 |
0.342 |
|
| 2010 |
Bailey MM, Berkland C. Therapeutic Particles and Biomaterials Technology Laboratory at the University of Kansas. Therapeutic Delivery. 1: 29-35. PMID 22816117 DOI: 10.4155/Tde.10.15 |
0.387 |
|
| 2010 |
Bailey MM, Mahoney CM, Dempah KE, Davis JM, Becker ML, Khondee S, Munson EJ, Berkland C. Fluorinated copolymer nanoparticles for multimodal imaging applications. Macromolecular Rapid Communications. 31: 87-92. PMID 21590842 DOI: 10.1002/Marc.200900505 |
0.784 |
|
| 2010 |
Aillon KL, El-Gendy N, Dennis C, Norenberg JP, McDonald J, Berkland C. Iodinated NanoClusters as an inhaled computed tomography contrast agent for lung visualization. Molecular Pharmaceutics. 7: 1274-82. PMID 20575527 DOI: 10.1021/Mp1000718 |
0.301 |
|
| 2010 |
Xie Y, Aillon KL, Cai S, Christian JM, Davies NM, Berkland CJ, Forrest ML. Pulmonary delivery of cisplatin-hyaluronan conjugates via endotracheal instillation for the treatment of lung cancer. International Journal of Pharmaceutics. 392: 156-63. PMID 20363303 DOI: 10.1016/J.Ijpharm.2010.03.058 |
0.554 |
|
| 2010 |
Wang Q, Wang J, Lu Q, Detamore MS, Berkland C. Injectable PLGA based colloidal gels for zero-order dexamethasone release in cranial defects. Biomaterials. 31: 4980-6. PMID 20303585 DOI: 10.1016/J.Biomaterials.2010.02.052 |
0.363 |
|
| 2010 |
Pickel L, Matsuzuka T, Doi C, Ayuzawa R, Maurya DK, Xie SX, Berkland C, Tamura M. Over-expression of angiotensin II type 2 receptor gene induces cell death in lung adenocarcinoma cells. Cancer Biology & Therapy. 9: 277-85. PMID 20026904 DOI: 10.4161/Cbt.9.4.10643 |
0.333 |
|
| 2010 |
Baoum A, Dhillon N, Buch S, Berkland C. Cationic surface modification of PLG nanoparticles offers sustained gene delivery to pulmonary epithelial cells. Journal of Pharmaceutical Sciences. 99: 2413-22. PMID 19911425 DOI: 10.1002/Jps.21994 |
0.317 |
|
| 2010 |
Staymates M, Fletcher R, Staymates J, Gillen G, Berkland C. Production and characterization of polymer microspheres containing trace explosives using precision particle fabrication technology. Journal of Microencapsulation. 27: 426-35. PMID 19860542 DOI: 10.3109/02652040903367335 |
0.359 |
|
| 2010 |
El-Gendy N, Desai V, Berkland C. Agglomerates of ciprofloxacin nanoparticles yield fine dry powder aerosols Journal of Pharmaceutical Innovation. 5: 79-87. DOI: 10.1007/S12247-010-9082-2 |
0.376 |
|
| 2010 |
Mohammadi Z, Wang X, Berkland C. Magnetic polyvinylamine nanoparticles by in situ precipitation reaction Journal of Polymer Science, Part a: Polymer Chemistry. 48: 991-996. DOI: 10.1002/Pola.23847 |
0.361 |
|
| 2010 |
Khondee S, Yakovleva T, Berkland C. Low charge polyvinylamine nanogels offer sustained, low-level gene expression Journal of Applied Polymer Science. 118: 1921-1932. DOI: 10.1002/App.32460 |
0.775 |
|
| 2010 |
Johnson S, Trejo J, Veisi M, Willhite GP, Liang JT, Berkland C. Effects of divalent cations, seawater, and formation brine on positively charged polyethylenimine/dextran sulfate/ chromium(III) polyelectrolyte complexes and partially hydrolyzed polyacrylamide/chromium(III) gelation Journal of Applied Polymer Science. 115: 1008-1014. DOI: 10.1002/App.31052 |
0.32 |
|
| 2009 |
Nune SK, Gunda P, Thallapally PK, Lin YY, Forrest ML, Berkland CJ. Nanoparticles for biomedical imaging. Expert Opinion On Drug Delivery. 6: 1175-94. PMID 19743894 DOI: 10.1517/17425240903229031 |
0.602 |
|
| 2009 |
Aillon KL, Xie Y, El-Gendy N, Berkland CJ, Forrest ML. Effects of nanomaterial physicochemical properties on in vivo toxicity. Advanced Drug Delivery Reviews. 61: 457-66. PMID 19386275 DOI: 10.1016/j.addr.2009.03.010 |
0.589 |
|
| 2009 |
El-Gendy N, Gorman EM, Munson EJ, Berkland C. Budesonide nanoparticle agglomerates as dry powder aerosols with rapid dissolution. Journal of Pharmaceutical Sciences. 98: 2731-46. PMID 19130469 DOI: 10.1002/Jps.21630 |
0.327 |
|
| 2009 |
Plumley C, Gorman EM, El-Gendy N, Bybee CR, Munson EJ, Berkland C. Nifedipine nanoparticle agglomeration as a dry powder aerosol formulation strategy. International Journal of Pharmaceutics. 369: 136-43. PMID 19015016 DOI: 10.1016/J.Ijpharm.2008.10.016 |
0.774 |
|
| 2009 |
Bailey MM, Berkland CJ. Nanoparticle formulations in pulmonary drug delivery. Medicinal Research Reviews. 29: 196-212. PMID 18958847 DOI: 10.1002/med.20140 |
0.316 |
|
| 2009 |
Huang M, Berkland C. Controlled release of repifermin from polyelectrolyte complexes stimulates endothelial cell proliferation. Journal of Pharmaceutical Sciences. 98: 268-80. PMID 18425807 DOI: 10.1002/Jps.21412 |
0.325 |
|
| 2008 |
Singh M, Morris CP, Ellis RJ, Detamore MS, Berkland C. Microsphere-based seamless scaffolds containing macroscopic gradients of encapsulated factors for tissue engineering. Tissue Engineering. Part C, Methods. 14: 299-309. PMID 18795865 DOI: 10.1089/Ten.Tec.2008.0167 |
0.327 |
|
| 2008 |
Peek LJ, Roberts L, Berkland C. Poly(D,L-lactide-co-glycolide) nanoparticle agglomerates as carriers in dry powder aerosol formulation of proteins. Langmuir : the Acs Journal of Surfaces and Colloids. 24: 9775-83. PMID 18680321 DOI: 10.1021/La8012014 |
0.416 |
|
| 2008 |
Huang M, Huang ZL, Bilgen M, Berkland C. Magnetic resonance imaging of contrast-enhanced polyelectrolyte complexes. Nanomedicine : Nanotechnology, Biology, and Medicine. 4: 30-40. PMID 18201943 DOI: 10.1016/J.Nano.2007.10.085 |
0.329 |
|
| 2008 |
Zhang N, Chittasupho C, Duangrat C, Siahaan TJ, Berkland C. PLGA nanoparticle--peptide conjugate effectively targets intercellular cell-adhesion molecule-1. Bioconjugate Chemistry. 19: 145-52. PMID 17997512 DOI: 10.1021/Bc700227Z |
0.383 |
|
| 2008 |
Shi L, Khondee S, Linz TH, Berkland C. Poly(N-vinylformamide) nanogels capable of pH-sensitive protein release Macromolecules. 41: 6546-6554. DOI: 10.1021/Ma800812Z |
0.783 |
|
| 2008 |
Cordova M, Cheng M, Trejo J, Johnson SJ, Willhite GP, Liang JT, Berkland C. Delayed HPAM gelation via transient sequestration of chromium in polyelectrolyte complex nanoparticles Macromolecules. 41: 4398-4404. DOI: 10.1021/Ma800211D |
0.357 |
|
| 2007 |
Shi L, Berkland C. Acid-Labile Polyvinylamine Micro- and Nanogel Capsules. Macromolecules. 40: 4635-4643. PMID 18797513 DOI: 10.1021/Ma070443O |
0.38 |
|
| 2007 |
Shi L, Plumley CJ, Berkland C. Biodegradable nanoparticle flocculates for dry powder aerosol formulation. Langmuir : the Acs Journal of Surfaces and Colloids. 23: 10897-901. PMID 17894513 DOI: 10.1021/La7020098 |
0.761 |
|
| 2007 |
Arnold MM, Gorman EM, Schieber LJ, Munson EJ, Berkland C. NanoCipro encapsulation in monodisperse large porous PLGA microparticles. Journal of Controlled Release : Official Journal of the Controlled Release Society. 121: 100-9. PMID 17604870 DOI: 10.1016/J.Jconrel.2007.05.039 |
0.404 |
|
| 2007 |
Berkland C, Pollauf E, Raman C, Silverman R, Kim K', Pack DW. Macromolecule release from monodisperse PLG microspheres: control of release rates and investigation of release mechanism. Journal of Pharmaceutical Sciences. 96: 1176-91. PMID 17455338 DOI: 10.1002/Jps.20948 |
0.778 |
|
| 2007 |
Huang M, Vitharana SN, Peek LJ, Coop T, Berkland C. Polyelectrolyte complexes stabilize and controllably release vascular endothelial growth factor. Biomacromolecules. 8: 1607-14. PMID 17428030 DOI: 10.1021/Bm061211K |
0.331 |
|
| 2007 |
Berkland C, Pollauf E, Varde N, Pack DW, Kim KK. Monodisperse liquid-filled biodegradable microcapsules. Pharmaceutical Research. 24: 1007-13. PMID 17372691 DOI: 10.1007/S11095-006-9197-9 |
0.774 |
|
| 2006 |
Dunehoo AL, Anderson M, Majumdar S, Kobayashi N, Berkland C, Siahaan TJ. Cell adhesion molecules for targeted drug delivery. Journal of Pharmaceutical Sciences. 95: 1856-72. PMID 16850395 DOI: 10.1002/Jps.20676 |
0.314 |
|
| 2006 |
Shi L, Berkland C. PH-triggered dispersion of nanoparticle clusters Advanced Materials. 18: 2315-2319. DOI: 10.1002/Adma.200600610 |
0.394 |
|
| 2005 |
Pollauf EJ, Berkland C, Kim KK, Pack DW. In vitro degradation of polyanhydride/polyester core-shell double-wall microspheres. International Journal of Pharmaceutics. 301: 294-303. PMID 16051452 DOI: 10.1016/J.Ijpharm.2005.06.004 |
0.778 |
|
| 2005 |
Raman C, Berkland C, Kim K, Pack DW. Modeling small-molecule release from PLG microspheres: effects of polymer degradation and nonuniform drug distribution. Journal of Controlled Release : Official Journal of the Controlled Release Society. 103: 149-58. PMID 15773062 DOI: 10.1016/J.Jconrel.2004.11.012 |
0.71 |
|
| 2004 |
Berkland C, Cox A, Kim K, Pack DW. Three-month, zero-order piroxicam release from monodispersed double-walled microspheres of controlled shell thickness. Journal of Biomedical Materials Research. Part A. 70: 576-84. PMID 15307162 DOI: 10.1002/Jbm.A.30114 |
0.65 |
|
| 2004 |
Berkland C, Pack DW, Kim KK. Controlling surface nano-structure using flow-limited field-injection electrostatic spraying (FFESS) of poly(D,L-lactide-co-glycolide). Biomaterials. 25: 5649-58. PMID 15159081 DOI: 10.1016/J.Biomaterials.2004.01.018 |
0.625 |
|
| 2004 |
Berkland C, Pollauf E, Pack DW, Kim K. Uniform double-walled polymer microspheres of controllable shell thickness. Journal of Controlled Release : Official Journal of the Controlled Release Society. 96: 101-11. PMID 15063033 DOI: 10.1016/J.Jconrel.2004.01.018 |
0.772 |
|
| 2004 |
Berkland C, Kipper MJ, Narasimhan B, Kim K, Pack DW. Microsphere size, precipitation kinetics and drug distribution control drug release from biodegradable polyanhydride microspheres Journal of Controlled Release. 94: 129-141. PMID 14684277 DOI: 10.1016/J.Jconrel.2003.09.011 |
0.643 |
|
| 2003 |
Berkland C, Kim K, Pack DW. PLG microsphere size controls drug release rate through several competing factors. Pharmaceutical Research. 20: 1055-62. PMID 12880292 DOI: 10.1023/A:1024466407849 |
0.653 |
|
| 2002 |
Berkland C, King M, Cox A, Kim K, Pack DW. Precise control of PLG microsphere size provides enhanced control of drug release rate. Journal of Controlled Release : Official Journal of the Controlled Release Society. 82: 137-47. PMID 12106984 DOI: 10.1016/S0168-3659(02)00136-0 |
0.642 |
|
| 2001 |
Berkland C, Kim K, Pack DW. Fabrication of PLG microspheres with precisely controlled and monodisperse size distributions Journal of Controlled Release. 73: 59-74. PMID 11337060 DOI: 10.1016/S0168-3659(01)00289-9 |
0.608 |
|
| Show low-probability matches. |